EUA

This authorisation follows conditional marketing authorisation from the UK MHRA, which was granted last month, and EUA from the…

The drugmaker in late January filed for Emergency Use Authorisation (EUA) of its COVID-19 shot for adults in the US

The companies also plan to submit these data to the European Medicines Agency (EMA) and other regulatory agencies around the world…

Biological E's Corbevax is being used to inoculate children against COVID-19 in the age group of 12 to 14 years

The EUA application was submitted on 22nd March by Prakash Kumar Singh, Director, Government and Regulatory Affairs, SII

Corbevax is India's first indigenously developed Receptor Binding Domain (RBD) protein sub-unit vaccine against COVID-19

DCGI has already approved CORBEVAX for restricted use in emergency situation among adults

The government is yet to decide on which segment of beneficiaries this new vaccine would be administered

Novavax has filed the complete CMC data package, which leverages Novavax's manufacturing partnership with the Serum Institute of…

With EUA, ZyCoV-D has also become the first vaccine to be administered to those in the age group of 12-18 years in the country